EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
暂无分享，去创建一个
A. Iwama | A. Kaneda | Y. Zen | T. Kanda | K. Aoyama | S. Nakamoto | Jian Jin | Anqi Ma | R. Muroyama | R. Nakagawa | H. Maruyama | T. Chiba | S. Ogasawara | E. Suzuki | M. Oshima | Tatsuya Kaneko | J. Kato | N. Mimura | Soichiro Kiyono | R. Mikata | S. Koide | S. Yasui | Masato Nakamura | T. Maeda | Ola Rizq | M. Otsuka | Kazufumi Kobayashi | Tomoko Saito | Hiroaki Kanzaki | Junjie Ao | Kengo Kanayama | Naoya Kato | Yuko Kusakabe | Kazumasa Aoyama | Shin Yasui | Atsushi Kaneda | Shingo Nakamoto